Advocate Group’s NeueHealth NEUE Stock Holding History

Advocate Group’s Portfolio NEUE Stock Details NEUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-150	Closed	-$2.64K	–	120
2023 Q1	$2.64K	Hold	150	–	–	﹤0.01%	120
2022 Q4	$7.8K	Buy	+150	New	+$10.9K	﹤0.01%	117

Other funds holding NEUE

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

Deer Management Company Larchmont, New York $812M AUM 2.64% 1-Year Est. Return

StepStone Group La Jolla, California $2.16B AUM 20.11% 1-Year Est. Return

Redpoint Management Woodside, California $204M AUM 31.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Greycroft New York $44.1M AUM 24.2% 1-Year Est. Return

Meritech Capital Associates VI Palo Alto, California $45.3M AUM 4.6% 1-Year Est. Return

Partners Group Holding Baar-Zug, Switzerland $1.47B AUM 8.59% 1-Year Est. Return

Harbourvest Partners Boston, Massachusetts $170M AUM 34.45% 1-Year Est. Return

Renaissance Technologies

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Advocate Group's NEUE Position: Q2 2023 in Review

Advocate Group sold out of NeueHealth (NEUE) in Q2 2023, closing a stake of 150 shares — an estimated $2.64K sold.

Advocate Group first reported a position in NEUE in Q4 2022 and held it in 2 quarters. The position peaked at $7.8K in Q4 2022. 49 funds tracked by Wall St. Rank hold NEUE as of Q2 2023.

Advocate Group reported no remaining NeueHealth position as of Q2 2023 after selling out during the quarter.
Advocate Group sold 150 NeueHealth shares in Q2 2023, an estimated $2.64K.
Advocate Group first reported a position in NeueHealth in Q4 2022 and held it in 2 quarters.
Advocate Group's NeueHealth position peaked at $7.8K in Q4 2022.
49 funds tracked by Wall St. Rank held NeueHealth as of Q2 2023.

Based on Advocate Group's 13F filing for Q2 2023, filed 20 Jul 2023.